NxStage(R) CEO and Founder to Participate in Innovator’s Panel Discussion at the Liquidnet Forum: How the Healthcare Market is Curing Itself
LAWRENCE, Mass., Jan 28, 2010 /PRNewswire via COMTEX/ — NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer and founder, will participate in the Technological Enablers of Healthcare Disruption panel discussion being held at the Liquidnet Forum™ on Thursday, February 4, 2010, at the Boston Intercontinental Hotel in Boston, Mass.
The Liquidnet Forum is a new series designed for investors and thought leaders looking for insights into innovations that will define the next generation of investment opportunities.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the Company’s website at https://www.nxstage.com/.
About Liquidnet
Liquidnet is the premier institutional investment community, bringing together the world’s largest asset managers and public companies on a single network that directly connects traders, portfolio managers, analysts and corporate issuers. Liquidnet enables Members of its community to achieve greater performance by moving from investment idea to implementation faster, ultimately retaining more alpha throughout the entire institutional investment cycle. Launched in 2001, the Liquidnet community extends to 30 equity markets across five continents. Liquidnet is headquartered in New York with offices in Boston, London, San Francisco, Chicago, Toronto, Tokyo, Hong Kong, Sydney and Singapore. For more information on the Liquidnet community, its liquidity, block executions, and additional investment capabilities, visit http://www.liquidnet.com/.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words anticipate, believe, expect, estimate, plan, and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Mr. Burbank’s plans to present at this conference. NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage’s expectations or beliefs as of any date subsequent to the date of this press release.
Contact:
Kristen K. Sheppard, Esq.
Investor Relations
ksheppard@nxstage.com
SOURCE NxStage Medical, Inc.
